mass spectrometry-based dna methylation profiling sequenom massarray epityper Search Results


96
agena bioscience methylation mass spectrometry
Methylation Mass Spectrometry, supplied by agena bioscience, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mass+spectrometry-based+dna+methylation+profiling+sequenom+massarray+epityper/Methylation/pmc06639569-128-0-4
Average 96 stars, based on 1 article reviews
methylation mass spectrometry - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

97
agena bioscience massarray system
Massarray System, supplied by agena bioscience, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mass+spectrometry-based+dna+methylation+profiling+sequenom+massarray+epityper/MassARRAY+System/custom%4010026%4022647397
Average 97 stars, based on 1 article reviews
massarray system - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

96
agena bioscience massarray-system-1
Massarray System 1, supplied by agena bioscience, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mass+spectrometry-based+dna+methylation+profiling+sequenom+massarray+epityper/massarray-system-1/custom%40massarray-system-1%4022647397
Average 96 stars, based on 1 article reviews
massarray-system-1 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

99
agena bioscience 17935-1
17935 1, supplied by agena bioscience, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mass+spectrometry-based+dna+methylation+profiling+sequenom+massarray+epityper/17935-1/custom%4017935-1%4010%2E11106%2Fcet%2E2014%2E7%2E2%2E118
Average 99 stars, based on 1 article reviews
17935-1 - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
agena bioscience all-mentions
All Mentions, supplied by agena bioscience, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mass+spectrometry-based+dna+methylation+profiling+sequenom+massarray+epityper/all-mentions/custom%40all-mentions%4038528048
Average 99 stars, based on 1 article reviews
all-mentions - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

86
Sequenom massarray system
Massarray System, supplied by Sequenom, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mass+spectrometry-based+dna+methylation+profiling+sequenom+massarray+epityper/massarray+platform/pmc04497431-60-12-14
Average 86 stars, based on 1 article reviews
massarray system - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

97
agena bioscience massarray analyzer 4 0
Massarray Analyzer 4 0, supplied by agena bioscience, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mass+spectrometry-based+dna+methylation+profiling+sequenom+massarray+epityper/MassARRAY+Analyzer+4/pm30341010-205-10-13
Average 97 stars, based on 1 article reviews
massarray analyzer 4 0 - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

86
Sequenom mass cleavetm
Mass Cleavetm, supplied by Sequenom, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mass+spectrometry-based+dna+methylation+profiling+sequenom+massarray+epityper/cleavetm+mass/pmc04497431-60-21-23
Average 86 stars, based on 1 article reviews
mass cleavetm - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

90
CapitalBio Corporation massarray platform
Massarray Platform, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mass+spectrometry-based+dna+methylation+profiling+sequenom+massarray+epityper/massarray+platform/pm25840961-60-1-4
Average 90 stars, based on 1 article reviews
massarray platform - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
CapitalBio Corporation sequence massarray platform
Hcy inhibited MFN2 transcriptional activities via DNMT1 in VSMCs. A, Analysis of MFN2 gene location, amplicon size and CpG islands in the amplicon. Methylation profile of CpG sites for MFN2 gene. B, The luciferase assay of activities of MFN2 promoter region (−1996/+1, −1043/+1, −885/+1, −783/+1 and −543/+1). ** P < 0.01, compared to MFN (−783/+1) group. C, <t>MassARRAY</t> Quantitative Methylation was performed to determine methylation status at the MFN2 promoter in VSMCs. Gray circles indicate not analysed methylation values owing to CpGs with high‐ or low‐mass Dalton peaks falling outside the conservative window of reliable detection for the EpiTYPER software, the colour of the circles represents the per cent of methylation in each CpG site. D, The proximal promoter region (−1403 to +1) of MFN2 was digested with McrBC, XhoI, HhaI, HpaI and HpaII to confirm the methylation status, then Dual‐Luciferase reporter assay was performed to ascertain the activity of the MFN2 proximal promoter differentially methylated with SssI, XhoI, HhaI, HpaI and HpaII methylase in VSMCs transfected with luciferase reporter constructs. E, MFN2 expressions in VSMCs were detected by qRT‐PCR and Western blot with the co‐treatment of Hcy and DNMT1, DNMT3a and DNMT3b specific inhibitor (DC05, TFD and nanaomycin A). F, DNMT1 expression was detected by qRT‐PCR and Western blot after VSMCs were incubated with 100 μmol/L Hcy. G and H, Quantification of DNA methylation and the expression of MFN2 in VSMCs after overexpression or knock‐down of DNMT1. I, Representative immunofluorescence images of DNMT1 (red) and VSMCs marker (α‐SMA, green) in APOE −/− mice, and nuclei were stained with DAPI (blue). Yellow indicated presence of both red and green staining, scale bar, 50mm. Quantification of the average DNMT1 intensity and co‐localization with α‐SMA was done, respectively. The experiment was performed in triplicate, and the representative images are shown. * P < 0.05, ** P < 0.01, compared to the APOE −/− +NC or Hcy+Ad‐GFP group, # P < 0.05, ## P < 0.01, compared to the Hcy+NC group
Sequence Massarray Platform, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mass+spectrometry-based+dna+methylation+profiling+sequenom+massarray+epityper/sequenom+massarray+platform/pmc06584594-76-0-3
Average 90 stars, based on 1 article reviews
sequence massarray platform - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Hcy inhibited MFN2 transcriptional activities via DNMT1 in VSMCs. A, Analysis of MFN2 gene location, amplicon size and CpG islands in the amplicon. Methylation profile of CpG sites for MFN2 gene. B, The luciferase assay of activities of MFN2 promoter region (−1996/+1, −1043/+1, −885/+1, −783/+1 and −543/+1). ** P < 0.01, compared to MFN (−783/+1) group. C, MassARRAY Quantitative Methylation was performed to determine methylation status at the MFN2 promoter in VSMCs. Gray circles indicate not analysed methylation values owing to CpGs with high‐ or low‐mass Dalton peaks falling outside the conservative window of reliable detection for the EpiTYPER software, the colour of the circles represents the per cent of methylation in each CpG site. D, The proximal promoter region (−1403 to +1) of MFN2 was digested with McrBC, XhoI, HhaI, HpaI and HpaII to confirm the methylation status, then Dual‐Luciferase reporter assay was performed to ascertain the activity of the MFN2 proximal promoter differentially methylated with SssI, XhoI, HhaI, HpaI and HpaII methylase in VSMCs transfected with luciferase reporter constructs. E, MFN2 expressions in VSMCs were detected by qRT‐PCR and Western blot with the co‐treatment of Hcy and DNMT1, DNMT3a and DNMT3b specific inhibitor (DC05, TFD and nanaomycin A). F, DNMT1 expression was detected by qRT‐PCR and Western blot after VSMCs were incubated with 100 μmol/L Hcy. G and H, Quantification of DNA methylation and the expression of MFN2 in VSMCs after overexpression or knock‐down of DNMT1. I, Representative immunofluorescence images of DNMT1 (red) and VSMCs marker (α‐SMA, green) in APOE −/− mice, and nuclei were stained with DAPI (blue). Yellow indicated presence of both red and green staining, scale bar, 50mm. Quantification of the average DNMT1 intensity and co‐localization with α‐SMA was done, respectively. The experiment was performed in triplicate, and the representative images are shown. * P < 0.05, ** P < 0.01, compared to the APOE −/− +NC or Hcy+Ad‐GFP group, # P < 0.05, ## P < 0.01, compared to the Hcy+NC group

Journal: Journal of Cellular and Molecular Medicine

Article Title: Aberrant MFN2 transcription facilitates homocysteine‐induced VSMCs proliferation via the increased binding of c‐Myc to DNMT1 in atherosclerosis

doi: 10.1111/jcmm.14341

Figure Lengend Snippet: Hcy inhibited MFN2 transcriptional activities via DNMT1 in VSMCs. A, Analysis of MFN2 gene location, amplicon size and CpG islands in the amplicon. Methylation profile of CpG sites for MFN2 gene. B, The luciferase assay of activities of MFN2 promoter region (−1996/+1, −1043/+1, −885/+1, −783/+1 and −543/+1). ** P < 0.01, compared to MFN (−783/+1) group. C, MassARRAY Quantitative Methylation was performed to determine methylation status at the MFN2 promoter in VSMCs. Gray circles indicate not analysed methylation values owing to CpGs with high‐ or low‐mass Dalton peaks falling outside the conservative window of reliable detection for the EpiTYPER software, the colour of the circles represents the per cent of methylation in each CpG site. D, The proximal promoter region (−1403 to +1) of MFN2 was digested with McrBC, XhoI, HhaI, HpaI and HpaII to confirm the methylation status, then Dual‐Luciferase reporter assay was performed to ascertain the activity of the MFN2 proximal promoter differentially methylated with SssI, XhoI, HhaI, HpaI and HpaII methylase in VSMCs transfected with luciferase reporter constructs. E, MFN2 expressions in VSMCs were detected by qRT‐PCR and Western blot with the co‐treatment of Hcy and DNMT1, DNMT3a and DNMT3b specific inhibitor (DC05, TFD and nanaomycin A). F, DNMT1 expression was detected by qRT‐PCR and Western blot after VSMCs were incubated with 100 μmol/L Hcy. G and H, Quantification of DNA methylation and the expression of MFN2 in VSMCs after overexpression or knock‐down of DNMT1. I, Representative immunofluorescence images of DNMT1 (red) and VSMCs marker (α‐SMA, green) in APOE −/− mice, and nuclei were stained with DAPI (blue). Yellow indicated presence of both red and green staining, scale bar, 50mm. Quantification of the average DNMT1 intensity and co‐localization with α‐SMA was done, respectively. The experiment was performed in triplicate, and the representative images are shown. * P < 0.05, ** P < 0.01, compared to the APOE −/− +NC or Hcy+Ad‐GFP group, # P < 0.05, ## P < 0.01, compared to the Hcy+NC group

Article Snippet: Sequence MassARRAY platform (CapitalBio, Beijing, China), which was composed of matrix‐assisted laser desorption/ ionization time‐of‐flight (MALDI‐TOF) mass spectrometry and combined with RNA base‐specific cleavage was used to analyse MFN2 methylation quantitatively (Gen‐Bank Accession Number: NM_001127660.1 ).

Techniques: Amplification, Methylation, Luciferase, Software, Reporter Assay, Activity Assay, Transfection, Construct, Quantitative RT-PCR, Western Blot, Expressing, Incubation, DNA Methylation Assay, Over Expression, Knockdown, Immunofluorescence, Marker, Staining